Sensorion, a pioneering clinical-stage and gene therapy biotech company specializing in the development of novel therapies to restore, treat, and prevent within the field of hearing disorders, announces its interim annual results as of June 30, 2021 alongside its outlook for the remainder of 2021.
September 27, 2021
· 18 min read